​

RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

OverviewForecastFinancialsChart

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 4.84% institutional investors, 0.28% insiders, and 94.89% retail investors. Blackrock is the largest institutional shareholder, holding 6.32% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRAPT Therapeutics4.84%0.28%94.89%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.44M6.32%$7.44M
Column group1.33M4.93%$10.63B
Vanguard group1.19M4.40%$40.20M
D. e. shaw770.01K1.98%$1.22M
Adar1 capital management507.77K1.88%$13.10M
Ghost tree capital300.00K0.78%$915.00K
Altium capital management lp200.00K0.52%$610.00K
Summittx capital91.91K0.34%$2.37M
Nuveen asset management116.92K0.30%$184.74K
Norges bank100.30K0.26%$305.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Column group1.33M16.17%$10.63B
Adar1 capital management507.77K1.23%$13.10M
Superstring capital management lp34.45K0.88%$888.44K
Ghost tree capital300.00K0.29%$915.00K
Altium capital management lp200.00K0.25%$610.00K
Aju ib investment12.44K0.11%$99.50K
Summittx capital91.91K0.10%$2.37M
D. e. shaw770.01K0.00%$1.22M
Hap trading36.50K0.00%$4.91K
Vanguard group1.19M0.00%$40.20M

Top Buyers

HolderShares% AssetsChange
Vanguard group1.19M0.00%490.60K
Altium capital management lp200.00K0.25%200.00K
Norges bank100.30K-100.30K
Summittx capital91.91K0.10%91.91K
Aqr capital management88.37K0.00%88.37K

Top Sellers

HolderShares% AssetsChange
Medicxi ventures management (jersey)---2.79M
Tcg crossover management---2.58M
Fcpm iii services b.v.---1.83M
Orbimed advisors---1.64M
Rtw investments, lp---1.64M

New Positions

HolderShares% AssetsChangeValue
Altium capital management lp200.00K0.25%200.00K$610.00K
Norges bank100.30K-100.30K$305.92K
Summittx capital91.91K0.10%91.91K$2.37M
Aqr capital management88.37K0.00%88.37K$269.54K
Thrivent financial for lutherans53.99K0.00%53.99K$164.00K

Sold Out

HolderChange
Aster capital management (difc)-1.00
Srs capital advisors-1.00
Farther finance advisors-2.00
Advisor group-5.00
Quest partners-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202512-81.82%1,304,681-90.42%40.19%8-75.76%2-89.47%
Sep 30, 202512-75.51%730,587-95.69%20.07%4-33.33%5-88.10%
Jun 30, 20251-98.90%12,437-99.99%-0.01%--100.00%1-96.15%
Mar 31, 202591-4.21%131,135,9343.35%2430.23%41-33.87%2630.00%
Dec 31, 202490-5.26%114,301,746283.56%2935.01%5750.00%20-25.93%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.00M5.73%-
Vanguard Total Stock Mkt Idx Inv827.04K2.86%-
BlackRock Event Driven Equity Instl620.51K2.14%-
State Street® SPDR® S&P® Biotech ETF549.10K1.90%3.04K
Fidelity Growth Compy Commingled Pl S2.05M1.56%21.11K
Fidelity Growth Company Fund1.49M1.13%-18.17K
Fidelity Select Biotechnology273.23K0.94%10.00K
Vanguard US Total Market Shares ETF1.12M0.85%-
Fidelity SAI Merger Arbitrage225.00K0.78%100.00K
GAMCO Intl SICAV Merger Arbtrg I (USD)222.26K0.77%222.26K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 05, 2024Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICERSell$20.46K
Dec 21, 2023HO WILLIAM Chief Medical OfficerSell$54.20K
Nov 28, 2023HO WILLIAM Chief Medical OfficerSell$20.58K
Oct 03, 2023HO WILLIAM Chief Medical OfficerSell$39.42K
Aug 18, 2023HO WILLIAM Chief Medical OfficerSell$47.30K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 4.84%, followed by 0.28% insiders and 94.88% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 35.75%, which RAPT Therapeutics falls below.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Blackrock (2.44M shares, 6.32%), Column group (1.33M shares, 4.93%), and Vanguard group (1.19M shares, 4.40%). Together, they hold 15.65% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

Yes, BlackRock owns 6.32% of RAPT Therapeutics, totaling 2.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.44M$. In the last quarter, BlackRock decreased its holdings by -32.323K shares, a -1.31% change.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.17% of its assets in 1.33M RAPT Therapeutics shares, valued at 10.63B$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of RAPT Therapeutics shares, with 5.73% of its total shares outstanding invested in 2M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools